Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients

Journal of Diabetes and its Complications

Volumn 29, Issue 3, 2015, Pages 390-394

  Blaslov, K ^a   Bulum, T ^a   Duvnjak, L ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Adipokines; Dipeptidyl peptidase 4; Insulin resistance; Renal function; Type 1 diabetes

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL PEPTIDASE IV; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WHITE ADIPOSE TISSUE; BLOOD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 1; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84925359182     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.12.019     Document Type: Article

References (31)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl. 1 2010 S62 S69
2. S. Ansorge, K. Nordhoff, and U. Bank Novel aspects of cellular action of dipeptidyl peptid.ase IV/CD26 Biological Chemistry 392 2011 153 168
3. P. Arner The adypocite in insulin resistance: Key molecules and the impact of thiazolidinediones Trends in Endocrinology and Metabolism 14 2003 137 145
4. K. Blaslov, T. Bulum, K. Zibar, and L. Duvnjak Relationship between adiponectin level, insulin sensitivity, and metabolic syndrome in type 1 diabetic patients International Journal of Endocrinology 535906 2010 10.1155/2013/535906 (Epub 2013 Jul 17)
5. K. Blaslov, T. Bulum, K. Zibar, and L. Duvnjak Relationship between metabolic syndrome and meal induced glucagon like peptide-1 response in type 1 diabetic patients Journal of Diabetes 2014 10.1111/1753-0407.12194
6. R. Breitling Robust signalling networks of the adipose secretome Trends in Endocrinology and Metabolism 20 2003 1 7
7. M. Cnop, P.J. Havel, and K.M. Utzschneider Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex Diabetologia 46 4 2003 459 469
8. R.A. DeFronzo, R. Hendler, and D. Simonson Insulin resistance is a prominent fearure of insulin dependent diabetes Diabetes 31 1982 795 801
9. G. Firneisz, T. Varga, and G. Lengyel Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: A novel liver disease biomarker PLoS ONE 5 8 2010 e12226 10.1371/journal.pone.0012226
10. A. Fraser, R. Harris, N. Sattar, S. Ebrahim, and G. Davey Smith Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: The British Women's Heart and Health Study and meta-analysis Diabetes Care 32 2009 741 750
11. S. Ghosh, A. Collier, M. Hair, I. Malik, and T. Elhaad Metabolic syndrome in type 1 diabetes International Journal of Diabetes Mellitus 2 2010 38 42
12. A.J. Hanley, L.E. Wagenknecht, A. Festa, R.B. D'Agostino Jr., and S.M. Haffner Alanine aminotransferase and directly measured insulin sensitivity in a multi-ethnic cohort: The Insulin Resistance Atherosclerosis Study Diabetes Care 30 2007 1819 1827
13. A. Iwabuchi, T. Kamoda, M. Saito, H. Nozue, I. Izumi, and T. Hirano Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus Journal of Pediatric Endocrinology and Metabolism 26 11-12 2013 1093 1097
14. S. Kröller-Schön, and M. Knorr Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition Cardiovascular Research 96 2012 140 149
15. D. Lamers, S. Famulla, N. Wronkowitz, S. Hartwig, S. Lehr, and D.M. Ouwens Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome Diabetes 60 7 2011 1917 1925
16. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro III, and H.I. Feldman A new equation to estimate glomerular filtration rate Annals of Internal Medicine 150 2009 604 612
17. L. Liu, J. Liu, and W.T. Wong Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism Hypertension 60 2012 833 841
18. P.R. Mason, R. Jacob, J.J. Corbalan, R. Kubant, A. Ciszewski, and T. Malinski Effects of dipeptidyl peptidase-4 inhibition on endothelial nitric oxide release, bllod pressure and SICAM-1 levels in hypertensive rats Journal of the American College of Cardiology 59 13 2012 E1543
19. C. Mega, E. Teixeira de Lemos, H. Vala, R. Fernandes, J. Oliveira, and F. Mascarenhas-Melo Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat) Experimental Diabetes Research 2011 (162092)
20. S. Pilz, F. Rutters, and G. Nijpels Insulin sensitivity and albuminuria: The RISC study Diabetes Care 37 6 2014 1597 1603 10.2337/dc13-2573
21. G.M. Reaven Pathophysiology of insulin resistance in human disease Physiological Reviews 75 1995 473 486
22. I.E. Schauer, J.K. Snell-Bergeon, B.C. Bergman, D.M. Maahs, A. Kretowski, and R.H. Eckel Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes Diabetes 60 1 2011 306 314
23. A.L. Sun, J.T. Deng, and G.J. Guan Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease Diabetes & Vascular Disease Research 9 4 2012 301 308
24. L.M. Thorn, C. Forsblom, and J. Fagerudd Metabolic syndrome in type 1 diabetes. Association with diabetic nephropathy and glycemic control Diabetes Care 28 8 2005 2019 2024
25. K.T. Tonks, Y. Ng, and S. Miller Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects Diabetologia 56 4 2013 875 885 10.1007/s00125-012-2811-y Epub 2013 Jan 24
26. T. Varga, A. Somogyi, G. Barna, B. Wichmann, and G. Nagy Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes Pathology and Oncology Research 17 2011 925 930
27. M. Vučić Lovrenčić, V. Radišić Biljak, S. Božičević, M. Prašek, P. Pavković, and M. Knotek Estimating glomerular filtration rate (GFR) in diabetes: The performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria Clinical Biochemistry 45 18 2012 1694 1696
28. K.V. Williams, J.R. Erbey, D. Becker, S. Arslanian, and T.J. Orchard Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49 2000 626 632
29. F. Yang, T. Zheng, Y. Gao, A. Baskotan, T. Chen, and X. Ran Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: Result from the China National Diabetes and Metabolic Disorders Study PLoS ONE 9 3 2014 e92222 10.1371/journal.pone.0092222 (Published online Mar 19, 2014; PMCID: PMC3960228)
30. R. Yazbeck, G.S. Howarth, and C.A. Abbott Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends in Pharmacological Sciences 30 2009 600 607
31. H. Yki-Järvinen, E. Helve, and V.A. Koivisto Hyperglycemia decreases glucose uptake in type I diabetes Diabetes 36 8 1987 892 896